2186. Treatment-emergent resistance to ceftazidime-avibactam (CZA) is more common than ceftolozane-tazobactam (CT) among patients infected with multidrug-resistant (MDR) Pseudomonas aeruginosa

BACKGROUND: CZA and CT are front-line agents for treatment (tx) of MDR Pseudomonas aeruginosa; however, comparative data are lacking. The purpose of this study was to compare rates of tx-emergent resistance among patients (pts) with bacteremia or pneumonia at a single center. METHODS: Adult pts trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Sunish, Haidar, Ghady, Squires, Kevin M, Kline, Ellen G, Pogue, Jason M, McCreary, Erin K, Stellfox, Madison, Van Tyne, Daria, Shields, Ryan K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678909/
http://dx.doi.org/10.1093/ofid/ofad500.1808

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678909/
http://dx.doi.org/10.1093/ofid/ofad500.1808

Ejemplares similares